TrialEuropean journal of drug metabolism and pharmacokinetics2018
A Population Pharmacokinetic and Pharmacodynamic Analysis of RP5063 Phase 2 Study Data in Patients with Schizophrenia or Schizoaffective Disorder.
Marc Cantillon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.